Raymond James Financial Services Advisors’s Dynavax Technologies DVAX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-133,724	Closed	-$1.88M	–	3356
2021 Q4	$1.88M	Sell	133,724 -91,111	-41%	-$1.5M	﹤0.01%	1583
2021 Q3	$4.32M	Buy	224,835 +198,576	+756%	+$2.64M	0.01%	1051
2021 Q2	$259K	Sell	26,259 -392	-1%	-$3.56K	﹤0.01%	2823
2021 Q1	$262K	Sell	26,651 -5,051	-16%	-$41.6K	﹤0.01%	2717
2020 Q4	$141K	Buy	31,702 +21,300	+205%	+$96.4K	﹤0.01%	2805
2020 Q3	$45K	Buy	+10,402	New	+$74.2K	﹤0.01%	2775
2016 Q4	–	Sell	-16,382	Closed	-$172K	–	2359
2016 Q3	$172K	Buy	+16,382	New	+$235K	﹤0.01%	2076

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Raymond James Financial Services Advisors's DVAX Position: Q1 2022 in Review

Raymond James Financial Services Advisors sold out of Dynavax Technologies (DVAX) in Q1 2022, closing a stake of 133,724 shares — an estimated $1.88M sold.

Raymond James Financial Services Advisors first reported a position in DVAX in Q3 2016 and held it in 7 quarters. The position peaked at $4.32M in Q3 2021. 207 funds tracked by Wall St. Rank hold DVAX as of Q1 2022.

Raymond James Financial Services Advisors reported no remaining Dynavax Technologies position as of Q1 2022 after selling out during the quarter.
Raymond James Financial Services Advisors sold 133,724 Dynavax Technologies shares in Q1 2022, an estimated $1.88M.
Raymond James Financial Services Advisors first reported a position in Dynavax Technologies in Q3 2016 and held it in 7 quarters.
Raymond James Financial Services Advisors's Dynavax Technologies position peaked at $4.32M in Q3 2021.
207 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2022, filed 11 May 2022.